#IDMastodon @th_journal Understanding of the comparative effectiveness & safety of #apixaban in treating VTE in severe #renalfailure
#apixaban was found to be a favorable alternative to warfarin in treating VTE in patients with CKD. It show lower recurrence of VTE rates lower risk of major bleeding and minor bleeding.
https://www.sciencedirect.com/science/article/abs/pii/S0049384823002086?dgcid=raven_sd_aip_email#preview-section-snippets

#Cardiooncology Effectiveness & safety of #anticoagulants among #venousthromboembolism cancer patients with /WO #braincancer .#clinicalstudy of 30,586 patients with active cancer .#apixaban vs LMWH & warfarin was lower risk of rVTE, MB & CRNMB. MB for apixaban vs LMWH with a higher reduction among those with #braincancer @isth
📌 https://www.sciencedirect.com/science/article/abs/pii/S0049384823001019?dgcid=raven_sd_aip_email
📌 https://www.sciencedirect.com/journal/thrombosis-research

RT @TheWestonMale@twitter.com

.@denis_campbell@twitter.com
.@HEAL_COVID@twitter.com
.@HEAL_COVID@twitter.com
.@charlot_summers@twitter.com
.@mark_toshner@twitter.com
Covid blood-thinner drug treatment dangerous and does not work – study | The Guardian (story also in the FT earlier today) | 28 November 2022:
https://www.theguardian.com/world/2022/nov/28/covid-blood-thinner-drug-treatment-dangerous-and-does-not-work-study
#LongCovid #Apixaban

🐦🔗: https://twitter.com/TheWestonMale/status/1597231768171843584